J&J to buy cardio technology company Abiomed for $16.6B

Published November 1, 2022 3:51 am

By TOM MURPHY
AP Health Writer

Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division. The health care giant says it will pay $380 for each Biomed share and also provide another $35 per share in cash if some commercial and clinical milestones are met. Abiomed provides technology that treats coronary artery disease and heart failure. Abiomed sales jumped 22% to exceed $1 billion in its most recent fiscal year.

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KTVZ NewsChannel 21 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.